Create an Account
  1. Home
  2. Specialty
  3. Cataract & Refractive

Advances in Postoperative Care: Improving Outcomes and Patient Compliance

Advances in Postoperative Care Improving Outcomes and Patient Compliance
Media formats available:
Details
Presenters

  • Overview

    Despite the routine use of antibiotics, corticosteroids, and NSAID agents in postoperative ophthalmic care, there are no controlled investigations to establish the optimal regimens for topical agents after cataract surgery. The esteemed panel of experts discuss patient struggles with compliance related to topical medications and how novel, intraoperative approaches to postoperative pain and inflammation help quell these issues. Additionally, the latest government regulations on reimbursement are reviewed. There are lively discussions, debates, and questions from the previously recorded live audience, answered. 

    Supported through an unrestricted educational grant from Ocular Therapeutix.

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Explain the issues related to patient compliance with postoperative topical medications
    • Evaluate the benefits of delivery of antiinflammatory medications during cataract surgery
    • Summarize the drug delivery properties of novel sustained-release medications
    • Interpret the latest federal government regulations on reimbursement and how they will affect practice that treat Medicare-eligible patients
    • Interpret the latest federal government regulations on reimbursement and how they will affect practices that treat Medicare-eligible patients

    • Accreditation

      Provided by Evolve Medical Education

      Accreditation Statement
      Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

      Credit Designation Statement
      Evolve designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

      Successful completion of this CME activity, which includes participation in the evaluation component, earns credit toward the Lifelong Learning requirement[s] for the American Board of Ophthalmology’s Continuing Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting credit.

    • Participation Method

      In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

    • Faculty and Disclosures

      John A. Hovanesian, MD

      John A. Hovanesian, MD

      Clinical Instructor
      Jules Stein Eye Institute
      University of California Los Angeles
      Owner
      Harvard Eye Associates
      Laguna Hills, California


      Cathleen M. McCabe, MD

      Cathleen M. McCabe, MD

      Chief Medical Officer, Eye Health America
      Medical Director, The Eye Associates
      Bradenton, FL


      Cynthia Matossian, MD, FACS

      Cynthia Matossian, MD, FACS

      Founder and Medical Director 
      Matossian Eye Associates

      Doylestown, PA 
      Hopewell, NJ 

       


      DISCLOSURE POLICY
      It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.

      The following faculty/staff members have the following financial relationships with commercial interests:

      John A. Hovanesian, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Advisory Board: 1-800-Doctors, Aerie Pharmaceuticals, Abbott Medical Optics, Blephex, Cord, Eyedetec, Glaukos, Guardian Health Sciences, Ingenoeye, IOP/Katena, Ivantis, Kala, MDBackline, Ocular Therapeutix, Omeros, ReVision Optics, Shire, Sight Sciences, Tearlab,  Tearfilm Innovations, Valeant, and Veracity. Consultant:  1-800-Doctors, Acufocus, Aerie Pharmaceuticals, Alcon Vision, Allegro Ophthalmics, Allergan, Abbott Medical Optics, BlephEx,  Eyedetec, Glaukos, Guardian Health Sciences, IOP/Katena, Ivantis, Kala, Novartis, Ocular Therapeutix, Omeros, ReVision Optics, Sarentis ophthalmics, Sensimed, Shire, Tearlab, Tearfilm Innovations, Valeant, and Veracity. Grant/Research: Aerie Pharmaceuticals, Abbott Medical Optics, Alcon Vision, Allergan, Cloudbreak Therapeutics, Cord, Eydetec, Glaukos, Ingenoeye, IOP/Katena, Novartis, Ocular Therapeutix, Omeros, ReVision Optics, Shire, Tearfilm Innovations, and Valeant. Stock/Shareholder/Equity: Alcon Vision, Alicia Surgery Center, Allegro Ophthalmics, Allergan, BlephEx, Eyedetec, Glaukos, Guardian Health Sciences, Harvard Eye Associates, Harvard Hearing, Ingenoeye, MDBackline, Novartis, Ocular Therapeutix, RxSight, Sarentis Ophthalmics, Sight Sciences, and Tearfilm Innovations. Royalties: SlackBooks and TLC: The Laser Center.

      Cathleen M. McCabe, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Carl Zeiss Meditec, Eye Point Pharmaceuticals, Ocular Therapeutix, Novartis, Dompé, Bausch + Lomb, Ivantis, Omeros,
      and Sight Sciences. Grant/Research Support: Alcon Vision, Allergan, Dompé, Eye Point Pharmaceuticals, Glaukos, Johnson & Johnson Vision,
      Ocular Therapeutix, Ivantis, and Novartis. Speakers List: Allergan, Bausch + Lomb, Carl Zeiss Meditec, Dompé, Eye Point Pharmaceuticals, Ivantis, Novartis, Ocular Therapeutix, Omeros, and Sight Sciences. Stock/Shareholder: Engage Technologies and Ivantis.

      Cynthia Matossian, MD, FACS, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Aerie, Alcon, Allergan, Aramis Biosciences, Bausch + Lomb, Bruder Healthcare, Carl Zeiss Meditec, Checked-up, Conclusn, Dompe, EyePoint, EyeVance, Glint Pharmaceuticals, Guardian Health Services, Imprimis Pharmaceuticals, Johnson & Johnson Vision, Kala Pharmaceuticals, LacriSciences Vision, Legrand Health, Lenstec, Lumenis, Marco, MDBackline, Novartis, NuSight Medical, Ocular Science, Olympic, Omeros, Osmotica Pharmaceuticals, Physicians Recommended Nutraceuticals, Quidel, Regener-Eyes, Stepwise Medical and Sun Pharmaceuticals, Tearlab, TearSciences, Tissue Tech, Visionology, and Visus. Grant/Research Support: Dompe, Imprimis Pharmaceuticals, Johnson & Johnson, and Novartis. Speaker’s Bureau:  Alcon, Allergan, Bausch + Lomb, Carl Zeiss Meditec, EyePoint, EyeVance, Guardian Health Services, Imprimis Pharmaceuticals, Johnson & Johnson Vision, Kala Pharmaceuticals, LacriSciences, Lumenis, Novartis, NuSight Medical, Olympic, Omeros, Physicians Recommended Nutraceuticals, Sun Pharmaceuticals, Tearlab, TearSciences, and Tissue Tech. Stock/Shareholder: Checked-up, Physicians Recommended Nutraceuticals, Straspey Crown, and Veterinarian Recommended Solutions.

      The Evolve staff and planners have no financial relationships with commercial interests.
      Mark Goerlitz-Jessen, MD, peer reviewer, has no financial relationships with commercial interests.

    • Disclaimer

      OFF-LABEL STATEMENT
      This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

      DISCLAIMER
      The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Ocular Therapeutix.

    • System Requirements

      • Supported Browsers (2 most recent versions):
        • Google Chrome for Windows, Mac OS, iOS, and Android
        • Apple Safari for Mac OS and iOS
        • Mozilla Firefox for Windows, Mac OS, iOS, and Android
        • Microsoft Edge for Windows
      • Recommended Internet Speed: 5Mbps+

    • Publication Dates

      Release Date:

      Expiration Date:

    Ready to Claim Your Credits?

    You have attempts to pass this post-test. Take your time and review carefully before submitting.

    Good luck!

    LIVE ON REACHMD RADIOBack to live radio
    ReachMD Radio

    Loading...

    00:00
    00:00
      Register

      We're glad to see you're enjoying Evolve Medical Education…
      but how about a more personalized experience?

      Register for free